http://www.aegleabio.com
Aeglea BioTherapeutics, Inc. Company Intro
Aeglea BioTherapeutics is developing a new generation of human enzyme therapeutics as solutions for rare diseases. Click to learn more about our research.
Industry
Healthcare
Aeglea BioTherapeutics, Inc. Headquaters
805 Las Cimas Parkway
Austin,78746
United States
Aeglea BioTherapeutics, Inc. Share price
14 Sep 2022 08:33 GMT
$0.4973
-0.0 (-0.32 %)
Aeglea BioTherapeutics, Inc. Market cap
$30.183 M
WMC RANKING
2023
Aeglea BioTherapeutics, Inc. # 364
BiotechnologyLatest Aeglea BioTherapeutics, Inc. News
28 Mar 2023
Short Interest in Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE ...
Aeglea Biotherapeutics, Inc is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as...
28 Mar 2023
Short Interest in Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE ...
Aeglea Biotherapeutics, Inc is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as...
WMC Market Score
WMC Market to Revenue Score
Aeglea BioTherapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Aeglea BioTherapeutics, Inc. | USD | $0 | $80,668 | $-80,383 | $302M | 364 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Aeglea BioTherapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Aeglea BioTherapeutics, Inc. Post vs Top 4 Industry Competitors
Aeglea BioTherapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Aeglea BioTherapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Aeglea BioTherapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Aeglea BioTherapeutics, Inc. | 0 | 2.17 | 0.00 | 0 | 0 | 0 | 0.98 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
